Table of Contents
<< Previous Issue | May 2017 (Vol: 2017, Issue: 5) | Next Issue >> |
- Section: Licensing
-
Takeda and Finch to Develop Microbiotic Drug for Ulcerative Colitis
-
Novartis In-Licenses Dry-eye Drug to Challenge Shire and Allergan
-
Pfizer Collaborates with Sangamo on Gene Therapy Programmes for Haemophilia A
- Section: Mergers & Acquisitions
-
Becton Dickinson Acquires Fellow Medtech Bard for Massive US$24 B
-
Fresenius Acquires Akorn and Scoops Biosimilar Portfolio from Merck KGaA
- Section: Research & Development
-
AstraZeneca and Pieris Collaborate on Inhaled Treatment for Asthma
-
Sanofi and Exscientia to Develop Bispecific Molecules for Diabetes
-
OncoMed Forced to Regroup After Celgene-Partnered Drug Fails for a Second Time